# dNovo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dnovo

- Industry: Biotechnology
- Headquarters: San Jose, US
- Website: www.dnovobio.com
- Total disclosed funding: $2.7M
- Latest round: Seed (Jan 24, 2022)
- Investors on record: 7

## About

Based in California, US, and founded in 2018 by its CEO, Ernesto Lujan, dNovo, Inc., operates as a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand, treating baldness and other hair loss problems. In January 2022, dNovo, Inc., raised USD 2.7 million in seed funding from Felicis Ventures, Pioneer Fund, Soma Capital, Y Combinator, Ataria Ventures, Duro Ventures, and Yintai Investment Company.

dNovo offers optimized transplantation procedures that include the regeneration of human hair stem cells for people who lost their hair due to aging or conditions such as male pattern baldness. The company uses direct reprogramming technology to generate human hair stem cells that are seeded onto the human scalp to enhance hair growth.

## Funding rounds

- Seed, Jan 24, 2022, $2.7M — Felicis Ventures, Y Combinator, Soma Capital, Pioneer Fund, Ataria Ventures, Duro Ventures, Yintai Investment Company

## Investors

- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Soma Capital — Seed
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- Ataria Ventures (https://capitalatlas.ai/funds/ataria-ventures) — Seed
- Duro Ventures (https://capitalatlas.ai/funds/duro-ventures) — Seed
- Yintai Investment Company (https://capitalatlas.ai/funds/yintai-investment-company) — Seed